Problem with that kind of thinking is off label use would greatly cut into the reduce it market via the backdoor.
But if we can get Hikma and Dr. Reddy to settle the appeal via threatening to bring in an authorized generic partner (Teva preferably) we can make the market totally worthless to them and then they should settle and then we keep all the generics out. That is my plan...
A certain poster's constant repetition that an authorized generic partner would have no competitive advantage do not make it so.